Mersana Therapeutics diskutieren
Mersana Therapeutics
WKN: A2DTR7 / Symbol: MRSN / Name: Mersana Therapeutics / Aktie / Small Cap /
1,66 €
-0,28 %
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $10.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock, up previously from $1.00.
Ratings data for MRSN provided by MarketBeat
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Citigroup Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Weight Watchers International diskutieren